20101205
 Citing Fatigue, Pfizer CEO Quits   By Rockoff, Jonathan D, The Wall Street Journal,  Dec 6, 2010  The 55-year-old Mr. Kindler headed Pfizer during some of the company's most difficult times, as it prepared to lose patent protection for its top-selling drug, Lipitor, and it struggled to find profitable new therapies, dropping disappointments like inhalable insulin in 2008 after spending $2.8 billion to bring it to market.   
